HIV 1 News and Research

RSS

Study reveals antiviral properties of glycosaminoglycans against SARS-CoV-2

Glycosaminoglycans can inhibit cell invasion by acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and other coronaviruses, which supports the utilization of such therapeutics in the fight against coronavirus disease (COVID-19) – reports a new study available on the preprint server bioRxiv.

3 May 2020

South African COVID-19 lockdown may not avert outbreak

The study investigated the effect of the various interventions in South Africa on the outbreak, analyzing trends in South Africa before and after the national lockdown, which started on March 27, 2020. Africa has so far reported over 38,000 cases, a small number compared to the 3.25 million global cases as of April 30, 2020. South Africa has reported over 5,600, with Egypt and Morocco close behind.

30 Apr 2020

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

In the United States, hepatocellular or liver cancer deaths have doubled since 1979. Hepatitis C virus is the leading cause of liver cancer.

30 Apr 2020

New database catalogs peptides that may halt SARS-CoV-2 cell infection

In the quest for a highly specific and tailored treatment strategy against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent publication available on the preprint server bioRxiv describes a repository of designed peptides that interfere with the early stages of viral invasion process.

30 Apr 2020

WSU researchers crack the Lyme disease code

The next time a tick feeds on you, Washington State University researchers hope to make sure persistent arthritis caused by Lyme disease doesn't linger for a lifetime.

30 Apr 2020

Researchers identify link between COVID-19 cure rate and regional selenium status

An international team of researchers, led by Professor Margaret Rayman at the University of Surrey, has identified a link between the Covid-19 cure rate and regional selenium status in China.

29 Apr 2020

Scientists launch clinical trial to test the efficacy of HIV drug against COVID-19 infection

A team of scientists from St. Michael's Hospital, Sinai Health and Sunnybrook Health Sciences Centre have launched a clinical trial to understand whether an existing drug used for HIV treatment and prevention may work to prevent COVID-19 infection.

28 Apr 2020

Research on SARS-CoV-2 spike protein may lead to new vaccines and treatments

The virus that causes COVID-19 is studded on its exterior with "spike proteins," a key component in its ability to infect human cells. Two University of Georgia researchers, Rob Woods and Parastoo Azadi, are investigating the proteins and sugars on the surface of the virus with the goal of finding information that could lead to vaccines and therapeutics.

28 Apr 2020

Researchers develop a new, promising treatment for HIV

A novel means to prevent HIV infection was developed at the University of Nebraska Medical Center that could allow people with or at risk of acquiring the virus to take medicines once a year.

28 Apr 2020

Using neutralising antibodies in the fight against COVID-19

While many scientists and pharmaceutical companies are racing to develop a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, there is also an urgent need for a coronavirus disease (COVID-19) treatment. The potent virus has now spread to 210 countries and territories, affecting more than 3.04 million people. Now, a team of German scientists is working on using antibodies to prevent and treat COVID-19.

27 Apr 2020

Wits University releases first clinical data on COVID-19 in South Africa

For example, do they resuscitate patients even though the prospects of recovery are slim and the risk to the healthcare team high? How should healthcare workers respond?

27 Apr 2020

Study can lead the way to new treatment methods for hepatitis C in infants

Only about five per cent of the babies born to mothers with hepatitis C are themselves infected by the disease.

27 Apr 2020

Moving from document-based FP and STI guidelines to computerized clinical decision support

Regenstrief Institute has propelled the translation of existing human readable clinical guidelines into computerized clinical decision support for family planning and for sexually transmitted infections (STI).

25 Apr 2020

New computer model predicts suicide risk

Suicide is now the second most common cause of death among American youth. Fatal suicides rose 30 percent between 2000 and 2016, and 2016 alone saw 1.3 million nonfatal suicide attempts.

25 Apr 2020

Fear, isolation and stigma attached to COVID-19 impact mental health of Africans

Fear, isolation and stigma are impacting the mental health of Africans during the COVID-19 pandemic, scientists say.

24 Apr 2020

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Biosero has designed and implemented an automated lab workflow for Scripps Research Institute so researchers can accelerate the screening of COVID-19 drug therapy candidates.

24 Apr 2020

Research looks at best ways to tackle coronavirus crisis

A new study published in the journal Frontiers in Microbiology in April 2020 discusses the most attractive approaches among the broad spectrum of experimental and theoretical strategies being worked on to counter the COVID-19 pandemic.

24 Apr 2020

1.7 billion people at higher risk from COVID-19, study says

The COVID-19 pandemic affecting 185 countries and territories the world over has already claimed over 190,000 lives and sickened well over 2.7 million as of April 24, 2020. Research shows that most of these fatalities are in older people or those who have underlying medical conditions.

23 Apr 2020

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

With the stepwise easing of measures in Switzerland, it is pivotal to monitor for any new COVID-19 outbreaks and to contain them in a timely and effective manner.

23 Apr 2020

Breakthrough discovery in HIV research opens path to new, better therapies

New research on the human immunodeficiency virus (HIV) structure has revealed a promising novel drug target for treating it.

23 Apr 2020

HIV 1 News and Research

Study reveals antiviral properties of glycosaminoglycans against SARS-CoV-2

South African COVID-19 lockdown may not avert outbreak

Racial inequalities in liver cancer mortality increased after introduction of hepatitis C drugs

New database catalogs peptides that may halt SARS-CoV-2 cell infection

WSU researchers crack the Lyme disease code

Researchers identify link between COVID-19 cure rate and regional selenium status

Scientists launch clinical trial to test the efficacy of HIV drug against COVID-19 infection

Research on SARS-CoV-2 spike protein may lead to new vaccines and treatments

Researchers develop a new, promising treatment for HIV

Using neutralising antibodies in the fight against COVID-19

Wits University releases first clinical data on COVID-19 in South Africa

Study can lead the way to new treatment methods for hepatitis C in infants

Moving from document-based FP and STI guidelines to computerized clinical decision support

New computer model predicts suicide risk

Fear, isolation and stigma attached to COVID-19 impact mental health of Africans

Biosero and Scripps Research Institute offer automated lab screening for COVID-19 drug therapy candidates

Research looks at best ways to tackle coronavirus crisis

1.7 billion people at higher risk from COVID-19, study says

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

Breakthrough discovery in HIV research opens path to new, better therapies

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News